ASNC2025 Scientific Session and Exhibition CME / MOC Credit Claim-Main
(4)
Availability
On-Demand
Access expires on Jun 30, 2026
Cost
Visit ASNC.org to register for this event.
Credit Offered
41.5 CME Credits
41.5 MOC Points
41.5 COP Credits

Credit for  ASNC2025 will be offered in two stages. Claim credit only when you are done participating in all sessions (in-person and virtual).

  • Stage 1 – Claim credit for all sessions participated in for sessions occurring from Thursday, September 4 – Sunday, September 7.  
  • Stage 2 – Claim credit for the virtual activity on Saturday, September 13.
The evaluation / credit claim process for the Saturday, September 13 Technology and Techniques track opens on September 13.

ASNC2025 will provide you with top-notch education, opportunities to engage with your colleagues, and create new collaborations. Meet pioneers and leaders in nuclear cardiology and multimodality imaging who can help you navigate the field and where it is headed.

ASNC2025 will be offered in a hybrid format so you can attend in person in Orlando, FL or virtually from your home or office.

This course is intended for cardiologists, radiologists, nuclear medicine specialists, nuclear technologists, nurses, practice administrators, and other health care professionals with an interest in the field of nuclear cardiology.

At the end of this activity, participants will be able to:

  • Demonstrate improved skills in image interpretation and reporting
  • Recognize and minimize technical problems and artifacts that may be associated with cardiac imaging
  • Identify appropriate use of cardiac imaging techniques based on current guidelines
  • Evaluate new imaging technologies, software, and stress techniques
  • Identify the role of nuclear and cardiac CT imaging in overall patient care
  • Describe the importance of balancing radiation exposure with image quality
  • Describe future directions in cardiac PET, CT, and SPECT/CT to anticipate training and equipment needs
  • Identify the clinical implication of CT coronary angiography cases and recognize its value and limitations in clinical cardiology

This activity will increase learners’ competence in solving technical and clinical issues when treating patients with CVD. Sessions present different approaches to cardiac disease management to how to best improve patient outcomes. These sessions address topics in appropriate use criteria, SPECT best practices, PET best practices, new and emergent cardiac imaging procedures, lab performance and procedures, radiation safety, reporting, and lab performance and the application of appropriate guidelines-based treatments.

To maintain competence and improve performance, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria). Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced. ASNC2025 is an educational activity designed to help imaging professionals on how to best improve outcomes for their patients with CVD.

Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this live activity for 41.5* AMA PRA Category 1 Credits™ and 41.5* ABIM MOC points for the in-person learning and this virtual only learning activity for 27* AMA PRA Category 1 Credits™ and 27* ABIM MOC points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME.

Nurse Practitioners: The American Academy of Nurse Practitioners Certification Board (AANPCP) recognizes attendance at continuing education offerings which provide AMA PRA Category 1 Credits™ for the purpose of recertification.

Successful completion of this CME activity enables the in-person participant to earn up to 41.5* medical knowledge Maintenance of Certification (MOC) points and the hybrid virtual only participant up to 27* medical knowledge Maintenance of Certification (MOC) points in the American Board of Internal Medicine (ABIM) MOC program. Participants will earn MOC points equivalent to the amount of CME for this other activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

*Credits subject to change.

ASNC has received the highest level of recognition, Accreditation with Commendation, from the Accreditation Council for Continuing Medical Education (ACCME). Accreditation with Commendation is awarded to CME providers that demonstrate compliance in all aspects of accreditation requirements and for demonstrating exemplary engagement with the environment in support of physician learning and physician quality improvement.

FACULTY/PLANNER/ABSTRACT PRESENTER DISCLOSURES

 

As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit of all its educational activities through the disclosure of all relationships with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All persons who influenced the content of this activity are required to disclose all relationships. The American Society of Nuclear Cardiology has reviewed these disclosures and resolved or managed all identified conflicts of interest through a peer review process.

 

The following individuals have nothing to disclose:

 

Abadie, Bryan

Abbott, Brian

Abohashem, Shady

Abuzaid, Ahmed

Adler, Rebecca

Adomako, Rees

Agarwal, Vikram

Ahmed, Ahmed Ibrahim

Akhter, Afroza

Al Badarin, Firas

Al Rifai, Mahmoud

Albosta, Michael

Aldajani, Ahmed

AlJaroudi, Wael

Aljizeeri, Ahmed

Alnabelsi, Talal

Alwan, Maria

Amin, Rutvi

Arvind, Shreya

Asif, Talal

Atieh, Khaled

Avery, Ryan

Azevedo Junior, Giovane

Azhar, Abdullah Zoheb

Balasubramanian, Suryakumar

Barton, Anna

Bawa, Danish

Bittar Carlini, Gianfranco

Blaker, Noah

Boczar, Kevin

Bois, John

Brandão, Simone

Brandt, Michael

Bravo, Paco

Brownell, Kyle

Budweg, Jeffery

Bullock-Palmer, Renée

Cai, Xinzhe James

Calderon, Laura

Calnon, Dennis

Campisi, Roxana

Carr, Chloe

Carvajal-Juarez, Isabel

Chaikijurajai, Thanat

Charbonne, Gael

Chen, Lu

Chidambaram, Vignesh

Chinnaiyan, Kavitha

Chiu, Ka Lun

Chow, Benjamin

Cremer, Paul

Crestanello, Juan

Crofts, Kathy

Csecs, Ibolya

Dai, Neng

de Moraes, Alyssa

DePuey, E.

Diaz Mayor, Diego

DiBlasio, Rebecca

Ding, Ding

Divakaran, Sanjay

Donohue, Joseph

Doukky, Rami

Dragomirescu, Catalin

Duran, Jessica

Dutta, Joyita

Duvall, Lane

Eduardo, Jose

El Harake, Lamis

El Mais, Huda

El Yaman, Ahmad

ElBallat, Ahmed

Erba, Paola Anna

Escobar, Sandra

Feher, Attila

Ferreira, Maria Joao

Gerodias, Ferdinand

Ghannam, Mohammad

Giannopoulos, Andreas

Giarratana, Anna

Gimelli, Alessia

Godwin, Lehman

Gonzalez Sanchez, David

Gucuk Ipek, Esra

Hage, Fadi

Hamandi, Mohanad

Hansen, Christopher

Haouzi, Alice

Hardewig, Iris

Harinstein, Matthew

Hart, Paul

Hasnie, Ammar

Hazaveh, Sara

Heidel, R.

Hendel, Robert

Higgins, Angela

Hobocan, Marissa

Holtz, Daniel

Horgan, Stephen

Howladar, Shahad

Hussain, Wajid

Hutt, Erika

Iragavarapu, Shrikar

Irizarry Berrios, Emanuel

Jedeon, Zeina

Jerome, Scott

Joseph, Lee

Jouni, Hayan

Ju, Min

Juweid, Malik

Kadoya, Yoshito

Kadwalwala, Mazhar

Keating, Friederike

Khalaf, Shaden

Khan, Abdul Wali

Khan, Mahir

Khan, Mirza

Kim, Timothy

Knight, Nicole

Knight, Stacey

Kyriakoulis, Ioannis

Lima, Bruno

Linscheid, Logan

Liu, Bolun

Lopes, Rafael

Lulu, Cao

Mackin, Maria

Madamanchi, Chaitanya

Maniar, Yash

Mathew, Jaison

McCall, Keisha

Memmott, Matthew

Mengesha, Bethlehem

Merani, Maria

Meretta, Alejandro

Mishra, Malay

Modi, Karnav

Motwani, Manish

Munshi, Hasan

Murillo-Garcia, David

Nielsen, Cybil

Okafor, Joseph

Olgun Kucuk, Hilal

Pavuluri, Swathi

Perumalla, Sanjana

Pizzi, María

Polk, Donna

Prakash, Sakthi Surya

Qian, Frank

Quiram, Benjamin

Rader, Valerie

Ramirez, Giselle

Rasheed, Shazia

Robles Cruz, Javier Alejandro

Rodriguez Lozano, Patricia

Roque, Albert

Saha, Shubhashis

Saleem, Mariam

Santangeli, Pasquale

Santos Samaritano Pereira, Matheus

Saunders, Emma

Schwartz, Ronald

Sciammarella, Maria

Shah, Khanjan

Shanbhag, Aakash Dhananjay

Shatla, Islam

Shetty, Mrinali

Shou, David

Siddiki, Mikail

Sivalokanathan, Sanjay

Slart, Riemer

Soulek, Diane

Souza, Sergio

Ssembajjwe, Brian

Sterling, Russell

Suzuki, Yasuyuki

Tandon, Suman

Thomas, Gregory

Thompson, Randall

Van Decker, William

Varma, Revati

Vasilakis, Georgia

Veeranna, Neal

Vijayakumar, Shilpa

Wang, Ke

Wang, Lei

Warren, Jaime

Weinberg, Richard

Wiefels, Christiane

Williams, Kim

Winchester, David

Woolley, Ann

Wright, Catherine

Wright, Donald

Xie, Boqia

Yahiro, Davi

Yamamoto, Atsushi

Zghyer, Fawzi

Zhang, Yaqi

Ziegner, Barbara

Zohora, Fatema Tuj

 

The following individuals have provided financial relationships with ineligible company whose primary business is producing, marketing, selling, re-selling, or distributing products used by or own patients, including computer software/hardware, related to the content of the educational presentation in which they are involved:

 

Agarwal, Subhashish - Advisory Board: Pfizer

Alexander, Kevin - Consulting Fee; Company/Organization; Arbor Biotechnologies, Alexion, Alnylam, BridgeBio, Novo Nordisk, Pfizer

Alharbi, Jamilah - 2024 ASNC/Pfizer Young Investigator in Cardiac Amyloidosis Research Award; Pfizer Global

Al-Mallah, Mouaz - Research Grant: Siemens, GE HealthCare; Consultant: Jubilant, Pfizer, Philips, Medtrace, GE HealthCare

Arumugam, Parthiban - Speaker Support: Blue Earth DiagNonestics, Ltd, IBA

Auer, Benjamin - Consulting Fee: Spectrum Dynamics Medical; Research/Grant or Contractor: General Electric Healthcare

Bateman, Timothy - Advisory Board: GEHC, Synektik; Consulting: GEHC; Intellectual Property Rights, Royalties Ownership Interest; CVIT, LLC

Benz, Dominik - Advisory Board: Astra Zeneca; Consultant: Pfizer, Astra Zeneca

Berman, Daniel - Consulting Fee; Bayer Healthcare, GE Healthcare. Royalty; QPS Software Royalties Cedars Sinai. Intellectual property rights; US8885905B2 in USA and WO patent WO2011069120A1, Method and System for Plaque Characterization.

Blankstein, Ron - Advisory Board: Caristo Inc.; Consulting Fee: Caristo Inc., Nonevartis Inc., NaNonex AI, Amgen Inc., Heartflow Inc.; Research/Grant or Contractor: NaNonex AI, Nonevartis Inc, Amgen Inc., Heartflow Inc

Bourque, Jamieson - Consultant: GE HealthCare

Chareonthaitawee, Panithaya - Consultant: GE HealthCare; Royalties: UpToDate

Clerc, Olivier - Research/Grant or Contractor; Company/Organization; NIH K99 HL175107, International Society of Amyloidosis, American Society of Nuclear Cardiology and Pfizer

Cuddy, Sarah - Advisory Board; Novo Nordisk, BridgeBio. Advisory Board, Research/Grant or Contractor; Ionis, Astra Zeneca, Alexion. Advisory Board, Research/Grant or Contractor; Astra Zeneca. Research/Grant or Contractor; Alnylam. Honoraria; Pfizer.

deKemp, Robert - Royalties and Research Funding: Jubilant DraxImage; Sofware License Revenues: INVIA Medical Solutions

Di Carli, Marcelo - Consulting: IBA, Bitterroot Bio, Valo Health, Sanofi, MedTrace; International Research Grant: Sun Pharma, Gilead Sciences; In-kind Institutional Research Support: Amgen

Dorbala, Sharmila - Consulting honoraria: Pfizer, Novo Nordisk, Alexion/Astra Zeneca; Research Grant: Pfizer, Attralus, Siemens, Phillips, GE HealthCare

Dziuk, Miroslaw - Research/Grant or Contractor; Synektik. Advisory Board; Affidea

Einstein, Andrew - Research Grants: NHLBI, IAEA, Alexion, Attralus, BridgeBio, Canon, GEHC, Intellia, Ionis, Neovasc, Pfizer; Advisory Board: Canon America Medical Systems; Authorship: Wolters Kluwer HC - UpToDate; Consultant: Artya

Ersözlü, Sara - Research/Grant or Contractor; Amicus Therapeutics. Speakers' Bureau; Amicus Therapeutics. Advisory Board; Amicus Therapeutics; Travel Support from Alnylam Pharmaceuticals.

Ferencik, Maros - Advisory Board: Elucid, Cleerly; Consulting Fee: Elucid, Cleerly, HeartFlow, BioMarin; Research/Grant or Contractor: Cleerly; *Stock Interest: Elucid

Gagliano, Laura - Salaried Employee or Owner; Company/Organization; Jubilant Radiopharma

Gallegos Kattán, Cesia - Educational Grant: Pfizer; Advisory Board: Pfizer, BridgeBio, Astra Zeneca; Consultant: Pfizer, BridgeBio, Astra Zeneca

Gropler, Robert - Research/Grant or Contractor; NIH, AHA EIC, Leducq Foundation. Consulting Fee; AHA.

Grossman, Gabriel - Consulting Fee: Pfizer; Speakers' Bureau: Pfizer, Nonevartis

Heller, Gary - Medical Advisor: Molecular Imaging Services

Huck, Daniel - AHA Career Development Award (23CDA1037589), NIH K23 Career Development Award (1K23HL171893)

Hyafil, Fabien - Stock Interest: Naogen Pharma; Consultant: Pfizer; Speaker: Curium Pharma, GE HealthCare

Jaber, Wael - Consultant: Boston Scientific, Pfizer

Kaviani, Sanaz - Salaried Employee or Owner; Jubilant Radiopharma

Kersting, David - Research/Grant or Contractor; Pfizer. Consulting Fee; Novartis. Speakers' Bureau; Pfizer

Kramer, Christopher - Consulting Fee: Eli Lilly; Research/Grant or Contractor: BMS, Cytokinetics

Lopez, Diana - Consulting Fee; New Amsterdam

Maddahi, Jamshid - Research Grant and Consultant: GE HealthCare

Malhotra, Saurabh - Speaker's Bureau/Advisory Board: Pfizer, Alnylam; Speaker's Bureau - AstraZeneca; Consultant: Viz.ai

Martin, Emily - Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); Attralus, Inc.

Masri, Ahmad - Research/Grant or Contractor; Pfizer, Ionis, Attralus, Cytokinetics, Janssen. Consulting Fee; Cytokinetics, BMS, BridgeBio, Pfizer, Ionis, Lexicon, Attralus, Alnylam, Haya, Alexion, Akros, Edgewise, Rocket, Lexeo, Prothena, BioMarin, AstraZeneca, Tenaya

Merlino, Denise - Consultant: Bracco Diagnostics, SNMMI, ASNC, American Geriatrics Society, American Psychiatric Society, American College of Chest Phy, American Thoracic Society

Miller, Edward - Research Grant - Eidos/BioBridge, Pfizer, Alnylam, Siemens; Consultant - Eidos/BioBridge, Pfizer, Synektik

Miller, Robert - Research Grant/Consultant - Pfizer

Moulton, Eric - Salaried Employee or Owner: Jubilant Draxlmage Inc. (dba Jubilant Radiopharma)

Moura, Filipe - Consultant - Janssen

Murthy, Venkatesh - Research/Grant or Contractor; Siemens. Consulting Fee; INVIA. *Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); General Electric, Cardinal Health, Ionetix. Advisory Board; Ionetix.

Namías, Mauro - Intellectual property rights; Company/Organization; Mauro Namías and Aley Palau San Pedro are co-inventors of the PCT/PT2022/050033 patent (https://patents

O'Gorman, Kevin - Ownership/Stock: Abbott Labs, Boston Scientific, Intuitive Surgical Inc, Eli Lilly & Co, Thermo Fischer Scientific, United Health Group, Viking Therapeutics, Doximity

Osborne, Michael - Consultant: WCG Imaging

Patel, Krishna - Research Grants - NIH, Jubilant, ACC Geriatric Cardiology Council

Phillips, Lawrence - Advisory Board: Pfizer; Consulting Fee: Nonevo Nonerdisk, Eli Lilly

Roby, Amanda - Speakers' Bureau; Company/Organization; donated all speaking fees and honoraria to UTHealth from Bracco Diagnostics

Ruddy, Terrence - Research/Grant or Contractor: Canadian Medical Isotope Ecosystem, Pfizer Global, Siemens Healthcare Limited

Sadeghi, Mehran - Salaried Employee or Owner: Boehringer Ingelheim (spouse employer)

Saeed, Ibrahim - Consulting Fee; Guidepoint, American Society of Nuclear Cardiology. Advisory Board; BridgeBio

Sanghani, Rupa - Consultant/Speaker - GE Healthcare

Saraste, Antti - Advisory Board: Astra Zeneca, Nonevo Nonerdisk, Pfizer; Speakers' Bureau: Astra Zeneca, Pfizer, Abbott, BMS; Institutional research contracts with Astra Zeneca, New Amsterdam pharma and Precordior

Shah, Nishant - Research Grant/Advisory Board - Pfizer; Advisory Board - BridgeBio

Singh, Vasvi - Research grant - ASNC and Pfizer; Speaker's Bureau - Pfizer, AstraZeneca, Alnylam; Consultant - BridgeBio

Slomka, Piotr - Software royalties - Cedars Sinai; Consulting - Synektik

Small, Gary - Honoraria: Pfizer, Alnylam, Jubilant

Smiley, Dia - Consultant: Alnylam

Soman, Prem - Research/Grant or Contractor; Company/Organization; Pfizer

Sorensen, Jens - Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); Company/Organization; Medtrace Pharma A/S

Sperry, Brett - Consulting Fee; Company/Organization; Pfizer, BridgeBio, Alnylam Pharmaceuticals, AstraZeneca

Stendahl, John - Other financial benefit; Site principal investigator for clinical research sponsored by Bristol Myers Squibb (no personal compensation received).

Tang, W. H. Wilson - Consulting Fee: Cardiol Therapeutics, Zehna Therapeutics, GeNonemics plc, Boston Scientific, Bristol Myers Squibb, Alexion Pharmaceuticals

Tarkin, Jason - Consulting Fee: AstraZeneca; Research/Grant or Contractor: AstraZeneca, SaNonefi

Tolbod, Lars - Stock Interest: MedTrace Pharma A/S

Vaishnav, Joban - Advisory Board - Pfizer; Speaker - Alnylam

Wall, Jonathan - Research/Grant or Contractor; Company/Organization; Attralus, Inc

Weber, Brittany - Advisory Board; Novo Nordisk, Horizon, Kiniksa.

Wilcox, Jane - Advisory Board: Abiomed, Cytokinetics, Boerhinger Ingelheim, Abbott, IONIS, FIRE1 Foundry; Consulting Fee: Abiomed, Cytokinetics; Research/Grant or Contractor: Abiomed; Speakers' Bureau: Boerhinger Ingelheim

Wolinsky, David - Consultant/Advisory Board - BridgeBio, Alnylam; Consultant - Expert Connect, viz.ai

Release Date: September 4, 2025
Expiration Date: June 30, 2026
(A fee will be charged for claiming credit after the expiration date)

This activity will take place September 4-13, 2025. 
Post-test, evaluation, and credit claim will be available through this online course until June 30, 2026.

The Amyloidosis track is supported by an unrestricted educational grant from BridgeBio.
American Society of Nuclear Cardiology 
10300 Eaton Place, Suite 301
Fairfax, VA  22030 
703-459-2555 | info@asnc.org | www.ASNC.org
Powered By